Related Experiment Video
Updated: May 10, 2026

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
Human parechovirus type 3 central nervous system infections in Israeli infants
Nesrin Ghanem-Zoubi1, Maayan Shiner, Lester M Shulman
1Infectious Diseases Unit, Rambam Health Care Campus, Haifa, Israel. n_ghanem@rambam.health.gov.il
Insights
Human parechoviruses (HPeV) caused CNS infections in young Israeli infants during summer 2008. Early PCR detection of HPeV in cerebrospinal fluid (CSF) is crucial for timely diagnosis and treatment in infants with fever or CNS illness.
Area of Science:
- Virology
- Pediatric Neurology
- Infectious Diseases
Background:
- Human parechoviruses (HPeV) are known causes of central nervous system (CNS) infections in children globally.
- The prevalence and impact of HPeV in Israeli infants with CNS infections were previously uncharacterized.
Purpose of the Study:
- To determine the detection rate of HPeV in enterovirus-negative cerebrospinal fluid (CSF) samples from Israeli children aged 0-5 years.
- To investigate the clinical presentation and outcomes of HPeV infections in infants.
Main Methods:
- Retrospective analysis of 367 CSF samples collected between 2007-2009 from children with suspected CNS infection or unexplained fever.
- Nested reverse transcription-polymerase chain reaction (RT-PCR) assay for HPeV RNA detection.
- Molecular sequencing for HPeV typing and analysis of medical records.
Main Results:
- Human parechovirus 3 (HPeV3) RNA was identified in 13 CSF samples (3.5% overall, 11.3% in infants <3 months during summer 2008).
- All HPeV3-positive cases occurred in infants under 3 months old and presented without pleocytosis.
- Affected infants recovered without short-term complications.
Conclusions:
- HPeV, particularly HPeV3, is a significant cause of summertime febrile/CNS illness in young infants in Israel during periods of high viral activity.
- Including HPeV PCR in CSF diagnostics for neonates and young infants with fever or CNS symptoms is recommended.
- Rapid HPeV identification can potentially reduce unnecessary antibiotic use and shorten hospitalization.
Introduction:
Human parechoviruses (HPeV) have been recognized as the causative agents of central nervous system (CNS) infection of infants and young children in different parts of the world. The role of HPeV in CNS infection of Israeli infants and children is unknown.
Objectives:
To assess the detection rate of HPeV in enterovirus RT-PCR-negative cerebrospinal fluid (CSF) samples obtained during the years 2007-2009 from children 0-5 years old with suspected CNS infection or from very young infants with unexplained fever in four medical centers in Israel.
Study Design:
A total of 367 CSF samples were retrospectively tested for the presence of HPeV RNA using nested RT-PCR assay. Positive samples were further typed on the basis of molecular sequencing. Retrospective analysis of the medical charts was performed.
Results:
HPeV3 RNA was detected in CSF obtained between May and September 2008 in 13 patients, all of whom were <3 months old (3.5% of all CSFs; 11.3% of all infants<3 months in 2008). The HPeV-positive CSF samples were without pleocytosis. All HPeV3-positive patients recovered without obvious short term sequelae.
Conclusion:
HPeV infection could play an important role in summertime febrile/CNS illness in young infants during specific years with high HPeV activity. PCR detection of parechoviral RNA in CSF should be included in the diagnostic evaluation of fever or CNS infection of neonates and very young infants. The rapid identification of HPeV in CSF could curtail unnecessary empirical antibiotic treatment and shorten hospital stay in selected patients.
More Related Videos
Related Concept Videos
Encephalitis l: Introduction
Arboviral Encephalitis
Viral Meningitis
Cytomegalovirus Disease
Encephalitis ll: Pathophysiology
Bacterial Meningitis II: Pathophysiology

